Rapid growth in the global pharma market brings both opportunities and challenges for pharmaceuticals manufacturers. Low priced generic versions are creating intense competition for some drugs, with consequent pressure on production costs. Drugs still in patent must overcome threats from counterfeiting. There is also a flow of new regulations, which means that companies have to respond and innovate.
Label converters are an essential resource in the pharma sector, and the products they create have to meet stringent specifications. Avery Dennison has the resources, the commitment to investment and the stable pharmaceutical products needed to achieve the best results. Our technical support is exceptional and we are one of the very few suppliers able to offer all adhesive technologies including hot melt, solvent and emulsion.
Putting patient safety first
High quality, reliable and efficient pharma labelling solutions are a critical part of patient safety. Low-migration products can be essential in many applications. Options such as tamper-evident containers, Radio Frequency Identification (RFID) labels and luminescent labels can also play a role. It is important to ensure a full range of labelling choices, to meet diverse needs.
High-specification and dependable products
Approval for a single self-adhesive pharmaceutical labelstock can take one to three years, and no element of the laminate can then be changed. Avery Dennison is committed to retaining dedicated pharma products and safeguarding long-term production. Our research programme is extensive, allowing new trends to be addressed, and heavy investment in our dedicated pharma plant at Bourg deThizy ensures outstanding product quality.
Global reach
Large savings can be made by rationalising labelling choices across different production facilities in different countries. Avery Dennison has the global reach needed to consult, specify and supply wherever production happens to be. We can help you to design more cost-effective labelling.